Central centrifugal cicatricial alopecia, or CCCA, is a type of scarring hair loss that begins at the crown of the scalp and gradually spreads outward in a circular pattern. It is the most common form of scarring alopecia in Black women, with prevalence estimates ranging from about 6 to 28 percent depending on the study. Unlike temporary hair loss conditions, CCCA permanently destroys hair follicles by replacing them with scar tissue, making early detection critical.
How CCCA Differs From Other Hair Loss
The word “cicatricial” means scarring, and that’s what sets CCCA apart from more familiar types of hair loss. In androgenetic alopecia (common pattern hair loss), follicles shrink and produce thinner hairs over time, but they remain alive beneath the skin. CCCA destroys follicles entirely. Scar tissue fills the space where the follicle once was, and no hair can grow from that spot again.
Pattern hair loss also tends to affect the vertex, crown, frontal hairline, or temples in a diffuse way and causes no physical discomfort. CCCA is symmetrical and radiates outward from the center of the scalp, often with noticeable symptoms like itching, tenderness, or a burning sensation. If you look closely at the affected area, the scalp may appear shiny or smooth, and any remaining hairs tend to be short, fragile, and brittle.
CCCA can also be confused with traction alopecia, which results from tight hairstyles pulling on hair follicles. Traction alopecia typically causes loss along the hairline or edges of the scalp rather than at the crown. However, the two conditions can overlap, and traction hairstyles are considered a risk factor for CCCA.
Early Symptoms to Recognize
CCCA often announces itself through scalp sensations before noticeable hair loss appears. Itching is the most common early complaint, frequently accompanied by burning, stinging, or tenderness at the crown of the scalp. These sensations tend to correlate with active inflammation underneath the skin. Some people also notice small pustules, papules, or scaling in the affected area.
The hair loss itself starts subtly. You might notice thinning right at the center or top of your head, with the area slowly widening over months or years. Because it begins in a spot that’s hard to see in a mirror, many people don’t realize something is wrong until significant loss has occurred.
What Causes the Scarring
The exact cause of CCCA is not fully understood, but the leading theory centers on a structural failure in the hair follicle itself. Each hair follicle has an inner lining called the inner root sheath that acts as a protective barrier. In CCCA, this lining breaks down prematurely. Once that barrier fails, chemicals, bacteria, and even the hair shaft itself can irritate the surrounding tissue, triggering an inflammatory response.
Immune cells, primarily a type of white blood cell called CD4+ T-cells, accumulate around affected follicles. Specialized immune cells called Langerhans cells also concentrate near the follicle’s stem cell region, potentially directing an immune attack against the very cells responsible for growing new hair. Over time, this persistent low-grade inflammation produces scar tissue (fibrosis) that replaces the follicle and cuts off its blood supply. In later stages, the follicle is completely destroyed and replaced by connective tissue.
Genetic and Hereditary Factors
A 2019 study published in the New England Journal of Medicine identified mutations in a gene called PADI3 in patients with CCCA. This gene produces an enzyme that plays a critical role in hair shaft formation, chemically modifying proteins that give the hair shaft its structure. The mutations found in CCCA patients caused the enzyme to misfold, reducing its activity and expression in scalp tissue.
Research in Black South African families has also identified an autosomal dominant inheritance pattern with partial penetrance, meaning the condition can run in families but doesn’t affect every person who carries the gene. This genetic susceptibility, combined with environmental and styling factors, may help explain why CCCA disproportionately affects women of African descent.
Styling Practices and Other Risk Factors
Certain hair care habits are consistently linked to a higher risk of developing CCCA, though they likely act as triggers rather than sole causes. Chemical hair relaxers show the strongest association. In one study, 85 percent of women with CCCA had used chemical relaxers, compared to 41 percent of controls, representing a roughly 12-fold increase in risk.
Traction hairstyles also play a role. Women with CCCA were more likely to have worn cornrows or braids with artificial hair, sewn-in weaves, or texturizers. Many reported experiencing damage, tenderness, or pulling from these styles. The proposed mechanism is that traction and chemical exposure act as a primary insult to the follicle, which then triggers the immune response that leads to scarring.
An unexpected comorbidity has also emerged in the research: women with CCCA have significantly higher rates of type 2 diabetes compared to women without the condition. Bacterial scalp infections are also more common in affected individuals. The relationship between these conditions and CCCA is still being studied, but it suggests the disease may involve systemic factors beyond the scalp.
How CCCA Is Diagnosed
A dermatologist can often suspect CCCA based on the pattern of hair loss, its location at the crown, and the presence of symptoms like itching or tenderness. But confirming the diagnosis requires a scalp biopsy. Under a microscope, early CCCA shows the premature breakdown of the inner root sheath surrounded by immune cells and early scar tissue forming around follicles.
In more advanced cases, the biopsy reveals destroyed follicles with fragments of hair shaft trapped in scar tissue, triggering a foreign-body reaction. A hallmark finding is polytrichia, where multiple hair follicles fuse together at the surface, creating the appearance of several hairs emerging from a single opening.
Treatment Options
Treatment for CCCA focuses on stopping inflammation and preventing further follicle loss. It cannot reverse scarring that has already occurred, which is why early intervention matters so much.
The most common first-line approach combines topical and injected steroids to reduce inflammation directly at the scalp. High-potency topical steroid solutions or foams are typically applied twice daily to the affected area. For more active disease, steroid injections into the scalp target deeper inflammation around the follicles.
Oral antibiotics in the tetracycline family are frequently prescribed alongside steroids, not for their antibacterial properties but for their anti-inflammatory effects. A common regimen is doxycycline taken daily for up to six months. The goal of these combined therapies is to quiet the immune activity long enough to preserve remaining follicles.
For cases that don’t respond to standard treatment, newer options are being explored. A class of medications called JAK inhibitors, which block specific immune signaling pathways, has shown early promise. In a phase 2a trial, CCCA patients treated with a JAK inhibitor showed improved hair loss severity scores at 24 weeks, with results sustained through 48 weeks. These drugs are not yet standard treatment for CCCA, but they represent an expanding set of options for resistant cases.
What Regrowth Is Realistic
The central challenge of CCCA is that it is a scarring condition. Once a follicle has been fully replaced by scar tissue, no treatment can bring it back. This is fundamentally different from non-scarring hair loss, where dormant follicles can potentially be reactivated.
However, not every follicle in the affected zone is necessarily beyond repair. In earlier stages, follicles that are inflamed but not yet fully scarred may recover with aggressive treatment. The goal shifts from regrowth to preservation: stopping the outward spread and protecting the follicles that still function. Some patients do see modest improvement in hair density when inflammation is brought under control, particularly around the edges of the affected area where follicles are in earlier stages of damage.
Adjusting hair care practices is also part of long-term management. Reducing or eliminating chemical relaxers, avoiding high-tension styles, and minimizing heat exposure can help lower the ongoing stress on vulnerable follicles. These changes won’t reverse existing scarring, but they remove triggers that may accelerate the disease’s progression.